The latest stem cell news, interviews, blogs and commentary

Scientists taking a stand

When scientists speak up for science, it can be a powerful thing indeed. We regularly observe this - in the direct interactions between scientists and school pupils or patient groups, for example, that are part of our public engagement and outreach work - but it also applies on the wider political stage.

Five years communicating stem cell research: how are we doing?

The end of February marks five years for EuroStemCell, and the end of this phase of our work, funded under the European Union's Seventh Framework Programme.

Over the past five years, we've approached the not insignificant challenge of communicating stem cell research across three distinct strands - informationeducation and conversation.

Europe approves Holoclar®, the first stem cell-based medicinal product

The European Commission has given Holoclar®, the first advanced therapy medicinal product (ATMP) containing stem cells, conditional marketing authorisation following a recommendation for approval by the European Medicines Agency.

Stem cells in the classroom

Not many researchers go directly into schools to teach science lessons, but that’s what Professor Ian Chambers from the MRC Centre for Regenerative Medicine did when he teamed up with EuroStemCell science communicator Emma Kemp. They have just published an academic paper on their experience of bringing stem cell research into schools. Here’s what they learned.

Europe-wide stem cell engagement: UniStem Day 2015 - 13th March 2015

The Seventh Edition of Unistem Day is getting closer! A day when school students all over Europe get the opportunity to engage with stem cell scientists and the latest stem cell research. 

Neural Stem Cells: meetings and scholarship opportunity

Two exciting opportunities for stem cell researchers working in the areas of neurodegeneration, brain repair and development.

Managing the potential and pitfalls of emerging stem cell therapies

While blood stem cells have been used clinically for over 40 years, it was the discovery of human embryonic stem cells in 1998, that has built expectations for people affected by a multitude of degenerative, chronic and fatal diseases with no cures or effective treatments. The speed with which therapies were expected to roll out of the lab did not take into consideration the complete lack of infrastructure required to make it happen, for many turning potential into frustration.

Centre for Bionetworking organises international conference on ‘Global life science and bionetworking’

On November 11th and 12th, stem cell scientists, clinicians and social scientists from around the world gathered at the University of Sussex to discuss and debate current practices around stem cell research and therapy in an international conference organised by the Centre for Bionetworking, Department of Anthropology. Specifically, delegates sought to answer the central question of the conference: What is there between bona fide and rogue stem cell therapy?

Training teachers in cutting edge stem cell research

PhD student Sara Schmidt, a researcher in the diabetes focused consortium HumEN, last week ventured away from the lab into a local High School to experience for the first time a taste of public engagement... here is how she got on. 


Clare Blackburn awarded prize for excellence with impact

With the drive for excellence in public engagement gaining momentum in the UK over the last 5 years, the UK Research Councils have teamed up to launch  the Excellence with Impact competition. 

Syndicate content